Prime Therapeutics paying $1.35 billion for Magellan Health’s pharmacy business

May 5, 2022

Star Tribune

Related news

In the news

May 5, 2022

Prime Therapeutics buying Magellan Health’s pharma business for $1.35 billion

Minneapolis/St. Paul Business Journal

In the news

April 13, 2022

BCBS Company Wins New Medicare Business

Health Payer Specialist

In the news

April 8, 2022

Oncology Innovation: Optimism & Obstacles

Pharmaceutical Commerce